Neurogene (NGNE) announced a peer-reviewed publication on its EXACT transgene regulation technology. The preclinical ...

Scientists have developed a new transgene control system that shows early promise for treating rare brain disorder Rett syndrome.

A collaborative study conducted by researchers at Maharishi International University (MIU), the University of Siegen, and the Uniformed Services University of the Health Sciences reveals ...

Nasopharyngeal carcinoma (NPC) is a malignant tumor originating from the nasopharyngeal epithelium. Due to its concealed location and nonspecific ...

WFS1 and CISD2 regulate IP3R activity through their interaction. In Wolfram syndrome, their dysfunction reduces cytosolic ...

Intermittent fasting, particularly the Ramadan Intermittent Fasting (RIF) model, has garnered significant attention in both ...

However, the artificial sweeteners market is hot. “Recent industry analysis reveals significant growth in the global artificial sweetener market, with projected values reaching US$ 10.30 billion by ...

Rather than a steady decline, the brain’s network stability followed a sigmoid, or S-shaped curve. It was stable until around ...

A new Drosophila collection of Parkinsonism models reveals early synaptic cholinergic projection neuron dysfunction, linking synaptic failure to later dopaminergic decline, highlighting a role for ...

Enliven Therapeutics, Inc. (Enliven or the Company) , a clinical-stage biopharmaceutical company focused on the discovery and development of small molecule therapeutics, today announced the Company ...

PepGen Inc. , a clinical-stage biotechnology company advancing the next generation of oligonucleotide therapies with the goal of transforming the treatment of severe neuromuscular and neurological ...